Notable Mergers and Acquisitions of the Day 2/18: GPCB
More News related to GPCB
- Notable Mergers and Acquisitions of the Day 2/18: GPCB
- GPC Biotech AG (GPCB) To Merge With Agennix
- GPC Biotech AG (GPCB) Reports That Marketing Authorization Application for Satraplatin is to Be Withdrawn
- Piper Jaffray Downgrades GPC Biotech (GPCB) to Underperform
- StreetInsider.com Pre-Open Movers 10/31
- GPC Biotech AG (NASDAQ: GPCB) and Agennix announced that the two oncology-focused biotechnology companies have signed a Business Combination Agreement under which they propose to merge their businesses.
In the transaction, GPC Biotech is to be merged onto a new German company, which will hold all of the shares of Agennix and a €15 million cash contribution by dievini Hopp BioTech holding GmbH & Co KG, an investment company of Dietmar Hopp, co-founder of SAP, and one of the largest shareholders of GPC Biotech.
The agreement assumes a merger ratio resulting in an economic ownership in the new company as follows: Agennix shareholders (approximately 48.0%), GPC Biotech shareholders (approximately 39.3%), and approximately 12.7% being attributed to the capital increase by dievini Hopp BioTech holding.
Related Categories
Special ReportsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
